The Future Of eCOA And Wearable Devices

Electronic Clinical Outcome Assessment (eCOA) wearables have revolutionized the collection of patient-reported data, enabling the handling of vast amounts of information in clinical research. As the volume and complexity of datasets continue to grow rapidly, the value of eCOAs becomes increasingly evident, offering innovative and convenient healthcare solutions for data collection and analysis. In 2022, the global eCOA solutions market was valued at $1.36 billion, and it is projected to maintain an annual growth rate of 15.2% from 2023 to 2030. Moreover, experts anticipate that wearable devices, particularly digital sensors, will be integrated into 70% of all clinical trials in the future.

With wearable devices becoming more advanced, user-friendly, and customizable to individual patient needs, there is significant potential to enhance patient engagement, compliance, and health outcomes. However, the next challenge for researchers lies in effectively collecting and managing these large datasets generated by the increased utilization of COA wearables.

Learn how by looking at the advantages of wearables and where they are headed in the future, manufacturers, providers, and researchers can better anticipate collaboration efforts to bridge the gaps in existing processes and maximize the potential of eCOA wearables in clinical research.